Duilio Brugnoni

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma.

Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 09, 2025

Updating ACC preclinical models: characterization of two new patient-derived cell lines.

Updating ACC preclinical models: characterization of two new patient-derived cell lines.

Journal: Endocrine-related cancer

Published: August 19, 2025

Regulating the future of laboratory medicine: European regulatory landscape of AI-driven medical device software in laboratory medicine.

Regulating the future of laboratory medicine: European regulatory landscape of AI-driven medical device software in laboratory medicine.

Journal: Clinical chemistry and laboratory medicine

Published: April 19, 2025

EN ISO 15189 revision: EFLM Committee Accreditation and ISO/CEN standards (C: A/ISO) analysis and general remarks on the changes.

EN ISO 15189 revision: EFLM Committee Accreditation and ISO/CEN standards (C: A/ISO) analysis and general remarks on the changes.

Journal: Clinical chemistry and laboratory medicine

Published: December 13, 2024

Diagnostic accuracy of bone marrow blood evaluation in haemophagocytic lymphohistiocytosis paediatric patients.

Diagnostic accuracy of bone marrow blood evaluation in haemophagocytic lymphohistiocytosis paediatric patients.

Journal: Annals of clinical biochemistry

Published: October 16, 2024

Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform.

Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform.

Journal: Nature medicine

Published: June 02, 2024

Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison.

Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison.

Journal: medRxiv : the preprint server for health sciences

Published: May 15, 2024

Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison.

Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison.

Journal: Brain : a journal of neurology

Published: May 02, 2024

Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA.

Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA.

Journal: Neurobiology of aging

Published: February 14, 2024

Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?

Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?

Journal: Blood cancer journal

Published: September 22, 2023

Analysis of annual distributions of hemoglobin A2 values as a method to test for HbA2 standardization.

Analysis of annual distributions of hemoglobin A2 values as a method to test for HbA2 standardization.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 13, 2023

Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment.

Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment.

Journal: Bioanalysis

Published: August 16, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026